Han, E., Mahévas, M., Comont, T., Audia, S., Gourguechon, C., Bonnard, G., Cheminant, M., Cortese, D., Ebbo, M., Haioun, C., Lobbes, H., Loiseau, P., Limal, N., Mausoleo, A., Riviere, E., Riviere, S., Robbins, A., Simand, C., Godeau, B., Michel, M., Crickx, E. (2025). Daratumumab can lead to long-lasting remissions in patients with refractory immune thrombocytopenia but with a high incidence of severe infections. Blood. https://doi.org/10.1182/blood-2025-4818